3 June 2019
The British Oncology Pharmacy Association recently published the BOPA Standards for Reducing Risks Associated with Electronic Prescribing and Medicines Administration Systems (ePMA) for Systemic Anti-Cancer Therapies (SACT). The document outlines steps that can be considered to be best practice in reducing the risks of errors arising from the introduction and use of e-prescribing systems for SACT within organisations. You may access the document via the SACT MIG Resources or click here.
If you have any queries please direct them to email@example.com